HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 58 filers reported holding HOOKIPA PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,038 | -31.3% | 6,555 | -1.8% | 0.00% | – |
Q2 2023 | $5,874 | -98.1% | 6,675 | -98.4% | 0.00% | – |
Q1 2023 | $316,138 | -8.0% | 429,535 | +1.2% | 0.00% | – |
Q4 2022 | $343,713 | -42.8% | 424,336 | -5.3% | 0.00% | – |
Q3 2022 | $601,000 | -18.2% | 448,296 | -0.7% | 0.00% | – |
Q2 2022 | $735,000 | -41.2% | 451,293 | -17.7% | 0.00% | – |
Q1 2022 | $1,249,000 | -25.6% | 548,070 | -23.9% | 0.00% | – |
Q4 2021 | $1,678,000 | +484.7% | 719,931 | +1378.9% | 0.00% | – |
Q3 2021 | $287,000 | -44.8% | 48,680 | -14.3% | 0.00% | – |
Q2 2021 | $520,000 | -39.9% | 56,782 | -11.7% | 0.00% | – |
Q1 2021 | $865,000 | +58.7% | 64,294 | +30.8% | 0.00% | – |
Q4 2020 | $545,000 | +28.2% | 49,154 | +9.5% | 0.00% | – |
Q3 2020 | $425,000 | -29.3% | 44,892 | -13.2% | 0.00% | – |
Q2 2020 | $601,000 | +69.3% | 51,733 | +20.0% | 0.00% | – |
Q1 2020 | $355,000 | +144.8% | 43,108 | +263.7% | 0.00% | – |
Q4 2019 | $145,000 | +49.5% | 11,854 | -7.8% | 0.00% | – |
Q3 2019 | $97,000 | +56.5% | 12,860 | +38.7% | 0.00% | – |
Q2 2019 | $62,000 | – | 9,270 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 1,842,902 | $17,452,000 | 0.32% |
Samsara BioCapital, LLC | 116,602 | $1,104,000 | 0.31% |
Artal Group S.A. | 599,616 | $5,678,000 | 0.14% |
HHLR ADVISORS, LTD. | 943,254 | $8,933,000 | 0.07% |
DAFNA Capital Management LLC | 22,061 | $209,000 | 0.07% |
Baker Brothers Advisors | 700,481 | $6,634,000 | 0.03% |
ZACKS INVESTMENT MANAGEMENT | 72,064 | $682,000 | 0.01% |
HOWLAND CAPITAL MANAGEMENT LLC | 14,728 | $139,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 14,374 | $139,000 | 0.00% |
Squarepoint Ops LLC | 12,699 | $120,000 | 0.00% |